NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Devices · USD

INVO Fertility, Inc. (IVF) Stock Analysis

INVO Fertility, Inc. (IVF) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

IVF

$0.55

−$0.05 (−8.98%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare IVF with… →

IVF Key Statistics

As of Oct 21, 2026
Trading
Open
$0.60
Previous Close
$0.60
Day's Range
0.53–0.60
52-Week Range
0.51–29.16
Volume
75.78K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.44
Valuation
Market Cap
$2.52M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.33
Financials (FY)
Revenue (FY)
$6.84M+4.73%
Net Income (FY)
−$23.32M
Profit marginThe share of revenue left as profit after all costs and taxes.
−92.30%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
4.60M
1-Year Return
−97.46%
Dividend and dates
Avg Volume
2.16M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, IVF closed at $0.55, −97.46% over 1 year.

INVO Fertility, Inc. (IVF) has a market capitalization of $2.52M.

In fiscal 2025, IVF reported revenue of $6.84M.

IVF Stock Return by Calendar Year

INVO Fertility, Inc. (IVF) return since Nov 2020: what $10,000 became

1 year
$10,000 $254
−97.46%
5 years
$10,000 $0.05
−99.9995%
Since Nov 2020
$10,000 $0.01
−99.9999%

If you had invested $10,000 in INVO Fertility, Inc. (IVF) at the close on November 2, 2020, the earliest close on record here, it would have been worth $0.01 at the close on October 21, 2026: −99.9999% in total, −89.73% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−85.46%
2025−99.68%
2024−40.00%
2023−84.08%
2022−87.27%
2021+10.63%
2020 (partial year)−79.90%

As of October 21, 2026.

IVF Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$6.84M−$23.32M−340.9%
2024$6.53M−$9.26M−141.7%
2023$3.02M−$8.03M−266.0%
2022$822.20K−$10.89M−1,324.8%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$6.84M$2.53M−$5.84M−$23.32M−340.9%
2024$6.53M$2.87M−$6.12M−$9.26M−141.7%
2023$3.02M$1.09M−$6.77M−$8.03M−266.0%
2022$822.20K−$28.57K−$10.63M−$10.89M−1,324.8%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

IVF Valuation vs Medical Devices Median

Median of 145 stocks
MetricIVFMedical Devices medianvs median
P/S ratio0.332.530.1x the median
Profit margin−92.30%−14.78%77.5 pts below

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

INVO Fertility, Inc. (IVF) is capitalised at $2.52M on the latest close. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 40.

Over the past 52 weeks the price has ranged from $0.51 to $29.16. The most recent close on file for IVF is $0.55, dated October 21, 2026. That is −$0.05 (−8.98%) against the previous close. The latest close sits 7.37% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $6.84M. Against the prior fiscal year total of $6.53M, that is a change of +4.73%. The same year closed with a net loss of $23.32M. Profit margin runs at −92.3%. That is 77.5 percentage points below the Medical Devices median of −14.78%.

Across the 4 fiscal years on file, revenue moves from $822.20K in 2022 to $6.84M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. Measured against sales, the shares trade at 0.33 times revenue. On price-to-sales that is 0.1 times the Medical Devices median of 2.53. The medians here are taken across 145 Medical Devices companies that report the metric.

Over the trailing twelve months the total return is −97.46%. Measured over 5 years, that is −91.35% a year compounded. The reported beta is 1.44. Daily returns over the trailing 6 years annualize to a volatility of 225.84%.

Growth & Income

No dividend is on file for IVF.

Across the complete calendar years on file, 2021 returned +10.63% and 2025 returned −99.68%. Of the 5 complete calendar years on file, 1 finished higher. 2026 is still running; the total return is −85.46% year to date.

Peer Comparison

INVO Fertility, Inc. (IVF) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
INVO Fertility, Inc. IVF $2.52M —
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About INVO Fertility, Inc.

INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services and INVOcell Device segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.

Visit website →